BioCentury
ARTICLE | Company News

Cipla, Lallemand Inc. sales and marketing update

March 4, 2013 8:00 AM UTC

Lallemand's Lallemand Pharma AG affiliate granted Cipla rights to commercialize Polyvalent Mechanical Bacterial Lysates-based immunostimulant under the name Pulmigen in India. The product is recommend...